Skip to main content
Background graphic

Soundbite Medical is dedicated to developing clinically relevant and innovative solutions, enabled by our proprietary IVL technology platform, for the interventional treatment of challenging coronary and peripheral arterial diseases burdened by calcium. Founded in 2015, Soundbite Medical is a privately held medical device company with headquarters in Montreal with a research center in Sherbrooke, Canada and a wholly owned subsidiary in Georgia, USA.

Our Mission

We are dedicated to bringing patients back to an active lifestyle through our endovascular technologies. This purpose drives us to deliver clinically relevant solutions that enable the healthcare providers to raise the standard of care for patients. We foster a strong innovation culture with shared values, and a passionate and empowered team is at the center of what we do. Together, we celebrate patient wins and strive to be a trusted partner for the communities we serve while we generate value for our shareholders.

Our Founders

Martin Brouillette Martin Brouillette

Co-Founder and Chief Technology Officer

Martin holds a B. Eng. from McGill University and both a Master’s and a Doctorate in Aeronautics from the California Institute of Technology. He is currently a Professor in the Mechanical Engineering Department at the Université de Sherbrooke in Canada where he heads the Shock Wave Research Laboratory. Martin is the originator of several technology development projects in bio-engineering and micro-engineering, based on gas dynamics and shock wave physics. He is the holder of numerous patents for biomedical devices and sensor systems for aerospace applications and at the origin of three start-ups exploiting these technologies. He has held several leadership positions with Soundbite Medical and currently serves as Chief Technology Officer.

Louis-Phillippe Riel, PhD Louis-Phillippe Riel, PhD

Co-Founder and Director, Consumables

Louis-Philippe holds a B. Eng, Master’s and Doctorate in Mechanical Engineering from the University of Sherbrooke. As co-founder of Soundbite Medical, he developed the core crossing technology for the company. He has held various leadership positions within the company and current serves as Director of Product Development for the Disposables & Systems. Louis-Philippe is the co-inventor of numerous patents related to the Soundbite technology and authored or co-authored numerous publications.

Steven Dion, PhD Steven Dion, PhD

Co-Founder and Director, Console Operations

Steven holds a Doctorate in Mechanical Engineering from the Université de Sherbrooke where he developed a device for the non-invasive treatment of kidney stones. In parallel, he worked to adapt the technology for the cardiovascular space and founded Soundbite. His patented invention is the core technology driving Soundbite Medical products. He and his team have developed the first three generations of the Soundbite shock wave generator (the Console) and he is listed as an inventor on most of Soundbite’s patents. Earlier in his career, Steven worked at the LOCUS research laboratory (Université de Sherbrooke) where he did research and development on other patented medical devices such as a needle-less injector.

Steven Arless Steven Arless


Currently the MedTech Entrepreneur-in-Residence at Centech, Steve has directed and created several medical device companies, from inception to major financing and public stock offerings, in addition to advancing new medical devices from R&D to commercialization and global sales marketing. He served as CEO for Soundbite from inception until 2017. He has also served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD). Steve is also an angel investor in medical technology and is involved in mentorship and teaching of graduate students at McGill University and Concordia University interested in developing medical technology.

Our Team

Thomas E. Little Thomas E. Little

President and CEO

Thomas Little, CPA, ICD.D., is an accomplished executive with over 39 years of experience leading transformational change across organizations. Mr. Little served as the Executive Vice President of Bell Canada and President of Bell Business Markets, where he successfully implemented strategies to enhance the client experience by integrating wireless and wireline business groups and transforming the client experience. Prior to that, he helped build and operate successful Canadian technology companies, including as the President and CEO of VisualSonics Inc. and as EVP and GM at DICOM Information Technologies, both of which yielded successful liquidity events. Mr. Little is a Chartered Professional Accountant and holds an Honours Business Administration degree from the IVEY School of Business at the University of Western Ontario. Additionally, he has obtained an ICD.D. designation from the Rotman Directors Education Program. He is currently a director at AIMIA, Rise Asset Development, Soundbite Medical Solutions and an advisory board member of Curait Medical.

Matt Olson Matt Olson

Vice President, Product Development

Matt Olson has over twenty-three years of experience in the medical device industry, with seventeen of those years in leadership roles at successful emerging technology companies. He has held roles in R&D, Operations, Manufacturing, and Clinical Training across the span of his career. Most recently, Matt was the Vice-President of Engineering & Operations at NexGen Medical Systems. He also served as Vice-President of Research & Development at Bridgepoint Medical when acquired by Boston Scientific and Medtronic in 2012, and was Director of Operations at Teramed, acquired by Johnson & Johnson in 2001. Additionally, he has held several management positions at American Medical Systems (AMS) and Boston Scientific. Matt is listed as an inventor on twenty-two medical device patents. He holds a Bachelor of Science degree in Mechanical Engineering from North Dakota State University.

Suzanne Wallace, CRNP Suzanne Wallace, CRNP

Vice President, Marketing

Mrs. Suzanne Wallace has more than 10 years of experience with medical devices in various roles across marketing, education, and medical affairs. Previously, she served as Senior Director of Clinical Marketing for Vesper Medical overseeing all marketing activities for the pre-commercial start-up company based in Pennsylvania. Prior to that, Suzanne was the Director of Medical Education and Scientific Communications at Shockwave Medical where she had dual medical affairs and marketing responsibilities for their global portfolio of products. Earlier in her career, Mrs. Wallace was the Director of Field Marketing and Education in Medtronic’s Mechanical Circulatory Support Business (Heartware, Inc.) where she was responsible for all aspects of commercial marketing and customer training programs. Mrs. Wallace is a board-certified Nurse Practitioner with a post-master’s degree in family practice and a Master of Science in nursing with a specialization in emergency and critical care. She spent the majority of her clinical career at the Penn State Hershey Medical Center caring for patients with cardiovascular disease. She received her B.S.N. from Messiah College and both her M.S.N. and post-master’s certificate from Widener University. She is cited as author or co-author in more than 10 publications.

John Schultz John Schultz

Vice President, Clinical Development

John has over thirty years of clinical trial experience with products ranging from implantable insulin pumps and blood gas monitors, to a variety of interventional products used in peripheral vascular, cardiovascular, and electrophysiology procedures. He has held roles in clinical executive management and clinical project management across several emerging technology companies, many of which were successfully acquired. These include MiniMed Technologies (Medtronic), EndiCOR Medical (ev3/Medtronic), Endocardial Solutions (St. Jude Medical/Abbott), and BridgePoint Medical (Medtronic & Boston Scientific). John brings extensive experience in electrophysiology, as well as percutaneous interventional procedures, including thrombectomy and chronic total occlusion treatment in the cardiovascular, neurovascular and peripheral vascular settings. John is listed as an inventor on two U.S. patents, and is cited as an author or co-author on nine publications. He holds a Bachelor of Science in Biomedical Engineering from the University of Southern California.

Background graphic

Clinical Advisors

Dr. George Adams
UNC School of Medicine (Rex Hospital)
Raleigh NC, USA

Dr. Marianne Brodmann
Medical University of Graz
Graz, Austria

Dr. Dimitrios Karmpaliotis
Morristown Medical Center
Morristown, NJ, USA

Dr. Martin Leon
Columbia University Irving
Medical Centre
New York, NY, USA

Dr. Michael Lichtenberg
Arnsberg Vascular Center
Klinikum Hochsauerland
Arnsberg, Germany

Dr. Eric Therasse
University of Montreal Health Centre
Montreal, Canada

Dr. Eric Secemsky
Beth Israel Deaconess Medical Center
Boston, MA, USA

Dr. S. Jay Matthews
Bradenton Cardiology Center
Bradenton, FL, USA

Dr. Robert Beasley
Palm Vascular Centers Miami Beach
Coral Gables, FL, USA

Hands stacked together in a pile

Careers - Join Us!

At Soundbite Medical Solutions, we are looking to build a world class team!

If you are motivated and share our passion, energy and dedication to bringing innovative products to help improve patient lives, click on the open positions listed below to learn more about our open opportunities with us. Come and join the Soundbite Medical team at this exciting time!

Note: Principals only. As a general practice, Soundbite Medical will not accept unsolicited resumes or placement information from any source or agency other than directly from a candidate. Soundbite Medical will not pay a fee for any placement resulting from the receipt of an unsolicited resume. Recruiting agencies must obtain advance written approval from Soundbite before submitting resumes.

View Open Positions

Intellectual Property

Soundbite Medical products and inventions are protected by patents in the United States and elsewhere. To date, we have 12 distinct inventions resulting in 8 U.S. patents and 20 international patents issued. Patent coverage addresses the largest markets, including, but not limited to: United States, Europe, Japan and China. The more than 50 filings cover the core technology and the unique energy source in vascular treatments with a variety of minimally invasive and non-invasive devices for CTO crossing, vessel preparation, treatment and drug delivery.

Background graphic

Contact Soundbite Medical